Veterinary Medicines

4XLA kiemdodend speendipmiddel voor na het melken, 6,4 mg/ml + 26,4 mg/ml tepeldipoplossing voor runderen

Authorised
  • Sodium chlorite
  • (±)-LACTIC ACID
Download as PDF

Product identification

Medicine name:
4XLA kiemdodend speendipmiddel voor na het melken, 6,4 mg/ml + 26,4 mg/ml tepeldipoplossing voor runderen
Active substance:
  • Sodium chlorite
  • (±)-LACTIC ACID
Target species:
  • Cattle
Route of administration:
  • Teat use

Product details

Active substance and strength:
  • Sodium chlorite
    6.40
    milligram(s)
    /
    1.00
    millilitre(s)
  • (±)-LACTIC ACID
    26.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Concentrate for dip solution
Withdrawal period by route of administration:
  • Teat use
    • Cattle
      • Milk
        no withdrawal period
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG52A
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Cid Lines
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ferdinand Eimermacher GmbH & Co. KG
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 9490
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 1/11/2023
Updated on: 3/11/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."